Type 2 Diabetes Trial, Recruiting NCT07693296 Sponsor: Acibadem University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07693296
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Type 2 diabetes, based on the American Diabetes Association's diagnostic standards
  • People who are able to walk on their own and are physically capable of using a treadmill
  • People who do not have any current serious heart, neurological, or joint/bone conditions that would stop them from taking part in an exercise program
  • People whose diabetes or heart-related medications have not changed significantly in the past 3 months
  • People who are regularly seen by a doctor and whose condition is currently stable
  • People who have been fully informed about the study and have signed a written consent form

Who may not be able to join:

  • People with severe nerve damage in their feet or who have lost feeling in their feet and cannot sense pain or pressure
  • People who have had a foot or leg amputation
  • People who have a diabetic foot wound or severe skin problems that make walking difficult
  • People with an advanced form of diabetes-related eye disease that could put them at risk during exercise
  • People with severe diabetes-related kidney disease, based on specific blood and urine test results (confirm with trial site)
  • People with very high blood pressure that is not under control (confirm with trial site for exact numbers)
  • People with a very high fasting blood sugar level combined with signs of a serious complication called ketosis (confirm with trial site)
  • People with unstable chest pain, a heart attack within the past 6 months, or a history of serious heart rhythm problems
  • People with advanced heart failure classified as NYHA Class III or IV (a medical rating of heart failure severity — confirm with trial site)
  • People who have a long-term breathing or lung condition
  • People who have already been taking part in a regular exercise, sport, or physical therapy program within the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90216 500 41 95

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Acibadem University
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 June 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

6-Minute Walk Test (6MWT); Measurement of Peripheral Muscle Strength; Heart Rate Variability (HRV) - Root Mean Square of Successive Differences (RMSSD); Heart Rate Variability (HRV) - Standard Deviation of NN Intervals (SDNN); Heart Rate Variability (HRV) - Mean RR Interval; Heart Rate Variability (HRV) - LF/HF Ratio; Fatigue Severity Scale (FSS); Blood Test Results: Glycated Hemoglobin (HbA1c); Blood Test Results: Fasting Blood Glucose (FBG); Lipid Profile: Low-Density Lipoprotein (LDL) Cholesterol; Lipid Profile: High-Density Lipoprotein (HDL) Cholesterol; Lipid Profile: Triglycerides

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov